Veterinary Orthopedics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type, By Product, By Application, By End User, By Region & Competition, 2021-2031F

The Global Veterinary Orthopedics Market is projected to expand from USD 587.33 Million in 2025 to USD 978.52 Million by 2031, registering a CAGR of 8.88%. This industry sector encompasses the manufacture and supply of medical devices, instruments, and implants designed to treat musculoskeletal trauma, joint deformities, and bone fractures in animals. Major drivers fueling this market include the rising incidence of age-related osteoarthritis and obesity in companion animals, alongside the growing trend of pet humanization which raises the standard of care expected by owners. Furthermore, the increasing availability of veterinary health insurance provides essential structural support by offsetting surgery costs and maintaining demand for corrective procedures.

According to the American Pet Products Association, sales of veterinary care and products in the United States totaled $39.8 billion in 2024, demonstrating significant capital investment in the animal health sector that bolsters specialized treatment markets. Despite this robust financial performance, a major obstacle hindering wider market growth is the high expense associated with advanced orthopedic interventions. These costs limit accessibility for pet owners who lack insurance coverage and restrict market penetration in developing regions where price sensitivity is more pronounced.

Market Driver

The increasing prevalence of obesity and musculoskeletal disorders in companion animals serves as a major catalyst for the market, as excess weight significantly worsens joint degeneration and increases susceptibility to injuries such as cranial cruciate ligament ruptures. This physiological connection guarantees a consistent volume of cases necessitating surgical instrumentation and corrective implants. Data from UK Pet Food's 'Obesity Report 2024', released in October 2024, indicates that 50% of dogs and 43% of cats are classified as obese or overweight, underscoring a health crisis that directly fuels the orthopedic surgical pipeline. Moreover, Nationwide's 'Most Common Medical Conditions' report from April 2024 confirms that osteoarthritis remains one of the most frequent conditions affecting insured pets, reinforcing the widespread clinical need for effective musculoskeletal intervention and management.

Concurrently, the rising adoption of reimbursement policies and pet health insurance is fundamentally transforming market dynamics by rendering sophisticated orthopedic procedures financially feasible for a larger demographic. Expensive interventions, such as minimally invasive fracture repairs and total hip replacements, are becoming more accessible as insurance reduces the out-of-pocket expenses for owners. This structural change is evident in the sector's financial performance; for example, Trupanion reported a 22% increase in total revenue year-over-year in its 'Fourth Quarter and Full Year 2023 Results' from February 2024, highlighting the rapid growth of the insured population that supports sustained spending on specialized veterinary healthcare.

Market Challenge

The substantial costs linked to advanced orthopedic interventions create a significant barrier to the scalability of the Global Veterinary Orthopedics Market. Complex procedures like cruciate ligament repairs and total hip replacements demand specialized surgical skills, expensive instrumentation, and extensive post-operative rehabilitation, resulting in price points that are often prohibitive for uninsured pet owners. This economic hurdle effectively limits the market's reach to higher-income demographics, compelling a large segment of the potential client base to opt for palliative care or conservative medical management instead of surgical solutions. Consequently, the procurement of surgical instruments and implant utilization remain suppressed, particularly in emerging economies with lower discretionary spending on animal healthcare.

This sensitivity to price has caused a tangible contraction in the consumption of veterinary services, directly impacting the orthopedics sector. According to the American Veterinary Medical Association (AVMA), overall veterinary spending decreased by 4% in 2024 compared to the prior year as owners struggled with escalating care costs. This reduction in capital flow illustrates how financial constraints force pet owners to prioritize essential services over high-cost specialized procedures, thereby dampening the revenue growth for orthopedic device manufacturers and impeding broader market penetration.

Market Trends

Advancements in limb-sparing technologies and total joint replacement are fundamentally changing clinical outcomes, shifting the market focus from simple fracture fixation to complex restorative solutions. This trend involves the development of custom-manufactured implants and modular prosthetic systems that enable surgeons to treat severe degenerative conditions and dysplasia that were previously considered untreatable. The industry's dedication to these specialized innovations is highlighted by the rapid pace of product development; according to Vimian Group's 'Year-end Report 2023' from February 2024, the company commercialized 111 new products during the fiscal year, aggressively expanding its portfolio to address unmet medical needs in specialized sectors like orthopedics. This strong emphasis on R&D guarantees a continuous supply of sophisticated instrumentation needed for high-level salvage procedures.

The adoption of AI-driven preoperative surgical planning tools is emerging as a vital efficiency driver, allowing veterinarians to automate the analysis of diagnostic imaging for precise trajectory modeling and implant sizing. By integrating artificial intelligence into radiographic workflows, orthopedic surgeons can significantly reduce preparation time and improve the accuracy of corrective osteotomies, thereby enhancing reproducibility and mitigating intraoperative risks. This digital shift is reshaping practice operations; as reported by Digitail and the American Animal Hospital Association (AAHA) in their 'AI in Veterinary Medicine' report from February 2024, 39.2% of veterinary professionals utilize AI tools in clinical settings, with imaging and radiology cited as primary applications. This facilitates more predictable surgical outcomes and supports the increasing complexity of orthopedic interventions offered at both referral and primary care levels.

Key Market Players

• B. Braun SE
• Vimian Group AB
• Integra LifeSciences Corporation
• AmerisourceBergen Corporation
• Arthrex, Inc.
• Orthomed (UK) Limited
• Animal Healthcare Services Ltd
• Narang Medical Limited
• Fusion Implants
• Medical Device Business Services, Inc.

Report Scope

In this report, the Global Veterinary Orthopedics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Orthopedics Market, By Animal Type

• Canine
• Feline
• Others

Veterinary Orthopedics Market, By Product

• Implants
• Instruments

Veterinary Orthopedics Market, By Application

• TPLO
• TTA
• Joint Replacement
• Trauma
• Others

Veterinary Orthopedics Market, By End User

• Veterinary Hospitals & Clinics
• Others

Veterinary Orthopedics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Orthopedics Market.

Available Customizations:

Global Veterinary Orthopedics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).